🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in users administering substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to TikTok, the platform has removed violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, populated with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.

Within moments of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant health risks”.